REFINVERSE Group, Inc. (TYO:7375)
Japan · Delayed Price · Currency is JPY 1,187.00
+7.00 (0.59%)
Aug 27, 2026, 3:30 PM JST
REFINVERSE Group Revenue
In the fiscal year ending June 30, 2026, REFINVERSE Group had annual revenue of 4.46B JPY with 9.68% growth. REFINVERSE Group had revenue of 1.13B in the quarter ending June 30, 2026, with 18.41% growth.
Revenue
4.46B
Revenue Growth
+9.68%
P/S Ratio
0.89
Revenue / Employee
22.43M
Employees
199
Market Cap
3.95B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 4.46B | 394.00M | 9.68% |
| Jun 30, 2025 | 4.07B | 218.00M | 5.66% |
| Jun 30, 2024 | 3.85B | -620.00M | -13.86% |
| Jun 30, 2023 | 4.47B | 740.00M | 19.83% |
| Jun 30, 2022 | 3.73B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Toho Acetylene | 34.88B |
| Taoka Chemical Company | 32.35B |
| Nankai Chemical Company,Limited | 21.18B |
| Daito Chemix | 19.83B |
| Maruo Calcium | 13.05B |
| MANAC Chemical Partners Co.,Ltd | 11.48B |
| Chemipro Kasei Kaisha | 9.47B |
| KNC Laboratories | 4.61B |